{"id":412942,"date":"2021-01-12T08:03:43","date_gmt":"2021-01-12T13:03:43","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=412942"},"modified":"2021-01-12T08:03:43","modified_gmt":"2021-01-12T13:03:43","slug":"uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/","title":{"rendered":"Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines<\/b><\/p>\n<p><i>Companies aim to build confidence in COVID-19 vaccines via Uber\u2019s global network of riders and drivers<\/i><\/p>\n<p>SAN FRANCISCO &amp; CAMBRIDGE, Mass.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nModerna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Uber Technologies, Inc. (NYSE: UBER), the world\u2019s leading ridesharing and delivery platform, today announced a collaboration to explore ways to help support the uptake of COVID-19 vaccines.\n<\/p>\n<p>\nModerna and Uber will work together initially to provide accessible, credible information on vaccine safety through Uber\u2019s in-app messaging. The two companies will also work with public health and other organizations to identify additional opportunities to support ongoing efforts to broaden access to COVID-19 vaccines. Additional options being evaluated include incorporating ride scheduling directly into the immunization appointment process, and possibly integrating with vaccine providers\u2019 systems to text reminders and enable patients to book rides in advance of their first or second immunization appointments.\n<\/p>\n<p>\n\u201cUsed by millions of people every day, the Uber platform can both help educate the public about vaccine safety and help eliminate transportation barriers to vaccination. Together with Moderna, we hope to do our part to help increase vaccination awareness and adoption, and we look forward to exploring ways we can help ensure everyone, especially in the hardest-hit communities of color, has access to a vaccine,\u201d said Uber CEO Dara Khosrowshahi.\n<\/p>\n<p>\n\u201cAs part of our commitment to help address COVID-19, Moderna will be working with a coalition of partners to educate, build trust around and increase awareness of the importance of vaccination in those communities significantly impacted by the pandemic. We look forward to combining our expertise with Uber\u2019s capabilities and platform to support this important effort,\u201d said Moderna CEO St\u00e9phane Bancel.\n<\/p>\n<p>\nIn December, Uber <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.uber.com%2Fnewsroom%2F10-million-rides%2F&amp;esheet=52360200&amp;newsitemid=20210112005245&amp;lan=en-US&amp;anchor=committed&amp;index=1&amp;md5=3681c60473e4dc8bb43d3b0bce6e0e92\">committed<\/a> 10 million free or discounted rides to help ensure transportation is not a barrier to getting a vaccine. Targeting communities hardest hit by the pandemic, Uber partnered with the National Urban League, National Action Network and the Morehouse School of Medicine. Uber will continue to build a broad coalition of organizations committed to breaking down transportation barriers in these communities.\n<\/p>\n<p>\nThe Moderna COVID-19 Vaccine has been authorized for emergency use in the U.S. by the FDA for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older and has been authorized by Health Canada for the immunization of Canadians 18 years of age and older under an Interim Order. The Moderna COVID-19 Vaccine has also been granted a Conditional Marketing Authorization by the European Commission, based upon the recommendation of the European Medicines Agency, which authorizes the COVID-19 Vaccine Moderna for active immunization to prevent COVID-19 caused by SARS-CoV-2 virus in individuals 18 years of age and older.\n<\/p>\n<p>\nWhile initially targeting Uber users in the United States, the companies anticipate expanding this partnership globally in the coming months alongside ongoing immunization efforts.\n<\/p>\n<p><span class=\"bwuline\">About Uber<\/span><\/p>\n<p>\nUber\u2019s mission is to create opportunity through movement. We started in 2010 to solve a simple problem: how do you get access to a ride at the touch of a button? More than 15 billion trips later, we&#8217;re building products to get people closer to where they want to be. By changing how people, food, and things move through cities, Uber is a platform that opens up the world to new possibilities.\n<\/p>\n<p><span class=\"bwuline\">About Moderna<\/span><\/p>\n<p>\nIn 10 years since its inception, Moderna has transformed from a science research-stage company advancing programs in the promising-but-still-unproven field of messenger RNA (mRNA), to an enterprise with its first medicine having treated millions of people, a diverse clinical portfolio of vaccines and therapeutics across six modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna\u2019s capabilities have come together to allow the authorized use of one of the earliest and most-effective vaccines against the COVID-19 pandemic.\n<\/p>\n<p>\nModerna\u2019s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases. Today, 24 development programs are underway across these therapeutic areas, with 13 programs having entered the clinic. Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.modernatx.com&amp;esheet=52360200&amp;newsitemid=20210112005245&amp;lan=en-US&amp;anchor=www.modernatx.com&amp;index=2&amp;md5=63868bb70cee2d8716fa8b6718756c53\">www.modernatx.com<\/a>.\n<\/p>\n<p><span class=\"bwuline\">Special Note Regarding Forward-looking Statements<\/span><\/p>\n<p>\nThis press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding collaborative efforts between Uber and Moderna to facilitate vaccination with the Moderna COVID-19 Vaccine and the provision of ridesharing services to customers by Uber. While Uber and Moderna each believes the forward-looking statements contained in this press release are accurate, these forward-looking statements represent the companies\u2019 beliefs only as of the date of this press release and there are a number of risks and uncertainties that could cause actual events or results to differ materially from those expressed or implied by such forward-looking statements. Those risks and uncertainties include, among other things, those risks listed under the heading \u201cRisk Factors\u201d in Uber\u2019s annual and quarterly reports filed with the Securities and Exchange Commission (SEC) and available through Uber\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.uber.com&amp;esheet=52360200&amp;newsitemid=20210112005245&amp;lan=en-US&amp;anchor=www.uber.com&amp;index=3&amp;md5=f5eef375c1ebbcf3330bf77e7d9a02da\">www.uber.com<\/a> and on the SEC\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=52360200&amp;newsitemid=20210112005245&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=4&amp;md5=ed1c38d03fb950415a2a1acca5881bd7\">www.sec.gov<\/a>, as well as those risks listed under the heading \u201cRisk Factors\u201d in Moderna\u2019s most recent quarterly report on Form 10-Q filed with the SEC and in subsequent filings made by Moderna with the SEC, which are available on Moderna\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.modernatx.com&amp;esheet=52360200&amp;newsitemid=20210112005245&amp;lan=en-US&amp;anchor=www.modernatx.com&amp;index=5&amp;md5=7d6bb0ef4828f78eadae6d4f44f01735\">www.modernatx.com<\/a> and on the SEC\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=52360200&amp;newsitemid=20210112005245&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=6&amp;md5=f75fc6ce0f42f03a1d6ec5934b21af56\">www.sec.gov<\/a>. Except as required by law, Uber and Moderna each disclaim any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210112005245r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210112005245\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210112005245\/en\/<\/a><\/span><\/p>\n<p>\nUber:<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:press@uber.com\">press@uber.com<\/a><\/p>\n<p>\nModerna:\n<\/p>\n<p>\nColleen Hussey<br \/>\n<br \/>Director, Corporate Communications<br \/>\n<br \/>617-335-1374<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Colleen.Hussey@modernatx.com\">Colleen.Hussey@modernatx.com<\/a><\/p>\n<p>\nHelen O\u2019Gorman<br \/>\n<br \/>FTI Consulting<br \/>\n<br \/>718-408-0800<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Helen.OGorman@fticonsulting.com\">Helen.OGorman@fticonsulting.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> California Massachusetts United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Software Mobile\/Wireless Networks Pharmaceutical Other Travel Public Transport Technology Infectious Diseases Travel Other Transport Transport Other Technology Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines Companies aim to build confidence in COVID-19 vaccines via Uber\u2019s global network of riders and drivers SAN FRANCISCO &amp; CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211; Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Uber Technologies, Inc. (NYSE: UBER), the world\u2019s leading ridesharing and delivery platform, today announced a collaboration to explore ways to help support the uptake of COVID-19 vaccines. Moderna and Uber will work together initially to provide accessible, credible information on vaccine safety through Uber\u2019s in-app messaging. The two companies will also work with public health and other organizations to identify additional opportunities to support ongoing efforts to broaden access to COVID-19 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-412942","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines Companies aim to build confidence in COVID-19 vaccines via Uber\u2019s global network of riders and drivers SAN FRANCISCO &amp; CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211; Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Uber Technologies, Inc. (NYSE: UBER), the world\u2019s leading ridesharing and delivery platform, today announced a collaboration to explore ways to help support the uptake of COVID-19 vaccines. Moderna and Uber will work together initially to provide accessible, credible information on vaccine safety through Uber\u2019s in-app messaging. The two companies will also work with public health and other organizations to identify additional opportunities to support ongoing efforts to broaden access to COVID-19 &hellip; Continue reading &quot;Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-12T13:03:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210112005245r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines\",\"datePublished\":\"2021-01-12T13:03:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\\\/\"},\"wordCount\":1114,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210112005245r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\\\/\",\"name\":\"Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210112005245r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-01-12T13:03:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210112005245r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210112005245r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/","og_locale":"en_US","og_type":"article","og_title":"Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines - Market Newsdesk","og_description":"Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines Companies aim to build confidence in COVID-19 vaccines via Uber\u2019s global network of riders and drivers SAN FRANCISCO &amp; CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211; Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Uber Technologies, Inc. (NYSE: UBER), the world\u2019s leading ridesharing and delivery platform, today announced a collaboration to explore ways to help support the uptake of COVID-19 vaccines. Moderna and Uber will work together initially to provide accessible, credible information on vaccine safety through Uber\u2019s in-app messaging. The two companies will also work with public health and other organizations to identify additional opportunities to support ongoing efforts to broaden access to COVID-19 &hellip; Continue reading \"Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-12T13:03:43+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210112005245r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines","datePublished":"2021-01-12T13:03:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/"},"wordCount":1114,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210112005245r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/","name":"Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210112005245r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-01-12T13:03:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210112005245r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210112005245r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uber-and-moderna-collaborate-to-raise-awareness-and-increase-access-to-covid-19-vaccines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/412942","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=412942"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/412942\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=412942"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=412942"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=412942"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}